Focus and Scope

Journal of Molecular Signaling encompasses all the molecular aspects of cell signaling involving receptors, G-proteins, kinases, phosphatases, and transcription factors in regulating cell proliferation, differentiation, apoptosis, and oncogenesis in mammalian cells.

Molecular signaling is an exponentially growing field that encompasses different molecular aspects of cell signaling underlying normal and pathological conditions. Specifically, the journal focuses on the normal or aberrant molecular mechanisms involving receptors, G-proteins, kinases, phosphatases, and transcription factors in regulating cell proliferation, differentiation, apoptosis, and oncogenesis in mammalian cells. This also includes the genetic and epigenetic changes that modulate the signaling properties of cells and the resultant physiological conditions.

Publication Frequency

The journal is published online as a continuous volume and issue throughout the year. Articles are made available as soon as they are ready to ensure that there are no unnecessary delays in getting content publicly available.

Special collections of articles are welcomed and will be published as part of the normal issue, but also within a separate collection page.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. There is no embargo on the journal’s publications. Submission and acceptance dates, along with publication dates, are made available on the PDF format for each paper.

Authors of articles published remain the copyright holders and grant third parties the right to use, reproduce, and share the article according to the Creative Commons license agreement.

Authors are encouraged to publish their data in recommended repositories. For a list of generic and subject specific repositories that meet our peer review criteria, see here.

Journal Archiving

The journal’s publishing services provider, Ubiquity Press, focuses on making content discoverable and accessible through indexing services. Content is also archived around the world to ensure long-term availability.

Ubiquity Press journals are indexed by the following services:

CrossRef, JISC KB+, SHERPA RoMEO, Directory of Open Access Journals (DOAJ), EBSCOHost, Cengage Learning, and Google Scholar. In addition, all journals are available for harvesting via OAI-PMH.

To ensure permanency of all publications, this journal also utilises LOCKSS archiving systems to create permanent archives for the purposes of preservation and restoration.

If the journal is not indexed by your preferred service, please let us know by emailing danny-dhanasekaran@OUHSC.edu or alternatively by making an indexing request directly with the service.

Advertisement Policy

The journal only displays advertisements that are of relevance to its scope and will be of interest to the readership (e.g. upcoming conferences). All advertising space is provided free of charge and the editor and publisher have the right to decline or withdraw adverts at any point.

If you wish to propose a potential advert then please contact the editorial team. All advert images will have to be provided to the publisher.

Annotation and post-publication comment

The journal platform permits readers to leave comments on the publication page, via the Disqus service. Readers will need a Disqus account to leave comments. Comments may be moderated by the journal, however, if they are non-offensive and relevant to the publication subject, comments will remain online without edit.

The journal platform also includes in-browser annotation and text highlighting options on full text formats via hypothes.is. Readers will require a hypothes.is account to create annotations, and will have the option to make these publicly available, available to a group, or private.

Journal History

Journal of Molecular Signaling was published by Biomed Central from 2006 to 2014. The Journal transferred to Ubiquity Press in January 2015. As of July 01 2021, the journal is published by Danny N. Dhanasekaran, with publishing services provided by Ubiquity Press Ltd.

Search Results

Searching for: NF-κB

.jnl-nr0sjg{display:inline-block;color:inherit;}.jnl-nr0sjg:hover{text-decoration:none;}Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-κB activity in melanoma cells

Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-κB activity in melanoma cells